Fred Alger Management’s 89bio ETNB Stock Holding History

Fred Alger Management’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,056	Closed	-$107K	–	532
2023 Q1	$107K	Buy	+7,056	New	+$92K	﹤0.01%	432

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Fred Alger Management's ETNB Position: Q2 2023 in Review

Fred Alger Management sold out of 89bio (ETNB) in Q2 2023, closing a stake of 7,056 shares — an estimated $107K sold.

Fred Alger Management first reported a position in ETNB in Q1 2023 and held it in 1 quarter. The position peaked at $107K in Q1 2023. 157 funds tracked by Wall St. Rank hold ETNB as of Q2 2023.

Fred Alger Management reported no remaining 89bio position as of Q2 2023 after selling out during the quarter.
Fred Alger Management sold 7,056 89bio shares in Q2 2023, an estimated $107K.
Fred Alger Management first reported a position in 89bio in Q1 2023 and held it in 1 quarter.
Fred Alger Management's 89bio position peaked at $107K in Q1 2023.
157 funds tracked by Wall St. Rank held 89bio as of Q2 2023.

Based on Fred Alger Management's 13F filing for Q2 2023, filed 14 Aug 2023.